Wagner Charles F Jr's Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed Mar 21, 2023
- Accession no.
- 0001209191-23-020244
- Filed
- Mar 21, 2023
- Trade date
- Mar 17, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions. Open-market sales total $592.8K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wagner Charles F JrCIK 0001223348 | Officer (EVP & Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 17, 2023 | Common Stock | SSaleDisposed | −360 | $294.52F2,F3 | −$106,027.2 | 53,019 | Direct | |
| Mar 17, 2023 | Common Stock | SSaleDisposed | −784 | $295.43F2,F4 | −$231,617.12 | 52,235 | Direct | |
| Mar 17, 2023 | Common Stock | SSaleDisposed | −240 | $296.30F2,F5 | −$71,112 | 51,995 | Direct | |
| Mar 17, 2023 | Common Stock | SSaleDisposed | −360 | $298.09F2,F6 | −$107,312.4 | 51,635 | Direct | |
| Mar 17, 2023 | Common Stock | SSaleDisposed | −240 | $299.58F2,F7 | −$71,899.2 | 51,395 | Direct | |
| Mar 17, 2023 | Common Stock | SSaleDisposed | −16 | $301.13 | −$4,818.08 | 51,379 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 5 transactions in Table I.
- F3
Open market sales reported on this line occurred at a weighted average price of $294.52 (range $293.98 to $294.81).
Referenced by the price of 1 transaction in Table I.
- F4
Open market sales reported on this line occurred at a weighted average price of $295.43 (range $295.09 to $295.97).
Referenced by the price of 1 transaction in Table I.
- F5
Open market sales reported on this line occurred at a weighted average price of $296.30 (range $296.14 to $296.45).
Referenced by the price of 1 transaction in Table I.
- F6
Open market sales reported on this line occurred at a weighted average price of $298.09 (range $297.65 to $298.48).
Referenced by the price of 1 transaction in Table I.
- F7
Open market sales reported on this line occurred at a weighted average price of $299.58 (range $299.09 to $300.06).
Referenced by the price of 1 transaction in Table I.